US President Trump announced a two-year tariff exemption for imported generic medicines, warning of steep 200% duties if production doesn't shift to the US afterward.
The move is part of Trump's broader strategy to boost domestic manufacturing
Jul 22, 2026
09:39 am
What's the storyUS President Donald Trump has announced a two-year exemption from tariffs on imported generic medicines.
However, he warned that if drug manufacturers do not shift production to the US, they could face duties of up to 100% initially and 200% later.
Indian pharma firms may yet survive Trump's 200% tariff bombshell
Trump’s 100% generic drug duty threatens US low-cost supply
Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive
Trump announces 0% tariff on generic medicines for two years; 200% thereafter
0, 100, 200: How Trump's latest generic medicines tariffs could affect India
Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% storm
Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investors
200% Trump tariff shock? India’s cheap pills may still beat US rivals
Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?
Trump Sets August 1 Start for Generic Drug Tariff Clock, Warns of 200% Duties: Companies Must 'Build Plan
Donald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry…
President Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from…
In a blow to India’s pharmaceutical industry, the Donald Trump administration has announced up to 200% tariffs on generic drugs…
U.S. President Donald Trump announces 100% tariff on branded pharmaceutical imports, pushing for U.S. manufacturing, impacting…
US President Donald Trump on Tuesday announced a phased tariff regime on imported generic medicines, saying they will continue to…
Indian drugmakers export around $9-10 billion worth of generic medicines to the American market every year. | India News
